Toll-like receptors in acute liver injury and regeneration

International Immunopharmacology

Volumn 11, Issue 10, 2011, Pages 1433-1441

  Chen, Yongyan ^a   Sun, Rui ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Innate immunity; Liver injury; Liver regeneration; TLR

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; MYELOID DIFFERENTIATION FACTOR 88; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ALCOHOL LIVER DISEASE; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; CELL POPULATION; CHRONIC HEPATITIS; COMPETITIVE INHIBITION; CYTOKINE PRODUCTION; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; INNATE IMMUNITY; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER REGENERATION; LYMPHOCYTE; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VIRION;

ANIMALS; FIBROSIS; HEPATITIS; HUMANS; LIGANDS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER REGENERATION; PORTAL SYSTEM; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 80053289164     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.04.023     Document Type: Review

References (134)

1. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147 163
2. G. Szabo, A. Dolganiuc, and P. Mandrekar Pattern recognition receptors: a contemporary view on liver diseases Hepatology 44 2006 287 298 (Pubitemid 44214866)
3. B.A. Beutler TLRs and innate immunity Blood 113 2009 1399 1407
4. C. Pasare, and R. Medzhitov Control of B-cell responses by Toll-like receptors Nature 438 2005 364 368 (Pubitemid 41643953)
5. S. Rakoff-Nahoum, and R. Medzhitov Role of toll-like receptors in tissue repair and tumorigenesis Biochemistry (Mosc) 73 2008 555 561 (Pubitemid 351775078)
6. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 2004 987 995 (Pubitemid 41057715)
7. + T cell trapping in the liver J Immunol 175 2005 1643 1650 (Pubitemid 41023067)
8. A. Mencin, J. Kluwe, and R.F. Schwabe Toll-like receptors as targets in chronic liver diseases Gut 58 2009 704 720
9. E. Seki, and D.A. Brenner Toll-like receptors and adaptor molecules in liver disease: update Hepatology 48 2008 322 335 (Pubitemid 351975556)
10. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511 (Pubitemid 38931765)
11. B. Beutler The Toll-like receptors: analysis by forward genetic methods Immunogenetics 57 2005 385 392 (Pubitemid 41396763)
12. R.F. Schwabe, E. Seki, and D.A. Brenner Toll-like receptor signaling in the liver Gastroenterology 130 2006 1886 1900 (Pubitemid 43668871)
13. K.A. Zarember, and P.J. Godowski Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 2002 554 561 (Pubitemid 34049553)
14. S. Liu, D.J. Gallo, A.M. Green, D.L. Williams, X. Gong, and R.A. Shapiro Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide Infect Immun 70 2002 3433 3442 (Pubitemid 34665980)
15. T. Matsumura, T. Degawa, T. Takii, H. Hayashi, T. Okamoto, and J. Inoue TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes Immunology 109 2003 127 136 (Pubitemid 36577983)
16. T. Matsumura, A. Ito, T. Takii, H. Hayashi, and K. Onozaki Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes J Interferon Cytokine Res 20 2000 915 921
17. J. Wu, Z. Meng, M. Jiang, E. Zhang, M. Trippler, and R. Broering Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific Immunology 129 2010 363 374
18. A. Uhrig, R. Banafsche, M. Kremer, S. Hegenbarth, A. Hamann, and M. Neurath Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver J Leukoc Biol 77 2005 626 633 (Pubitemid 40628742)
19. M. Martin-Armas, J. Simon-Santamaria, I. Pettersen, U. Moens, B. Smedsrod, and B. Sveinbjornsson Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides J Hepatol 44 2006 939 946
20. L. Bouwens, M. Baekeland, R. De Zanger, and E. Wisse Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver Hepatology 6 1986 718 722 (Pubitemid 16038195)
21. G.L. Su, R.D. Klein, A. Aminlari, H.Y. Zhang, L. Steinstraesser, and W.H. Alarcon Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4 Hepatology 31 2000 932 936 (Pubitemid 30169941)
22. B.M. Thobe, M. Frink, F. Hildebrand, M.G. Schwacha, W.J. Hubbard, and M.A. Choudhry The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage J Cell Physiol 210 2007 667 675 (Pubitemid 46185036)
23. J. Wu, M. Lu, Z. Meng, M. Trippler, R. Broering, and A. Szczeponek Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice Hepatology 46 2007 1769 1778
24. J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, and T. Tanizawa Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways Int Immunol 19 2007 311 320 (Pubitemid 46344696)
25. A. Meyer-Bahlburg, S. Khim, and D.J. Rawlings B cell intrinsic TLR signals amplify but are not required for humoral immunity J Exp Med 204 2007 3095 3101
26. T. Matsuguchi, K. Takagi, T. Musikacharoen, and Y. Yoshikai Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes Blood 95 2000 1378 1385 (Pubitemid 30099850)
27. M. Muzio, D. Bosisio, N. Polentarutti, G. D'Amico, A. Stoppacciaro, and R. Mancinelli Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells J Immunol 164 2000 5998 6004 (Pubitemid 30389848)
28. D. Xu, H. Liu, and M. Komai-Koma Direct and indirect role of Toll-like receptors in T cell mediated immunity Cell Mol Immunol 1 2004 239 246
29. M. Komai-Koma, L. Jones, G.S. Ogg, D. Xu, and F.Y. Liew TLR2 is expressed on activated T cells as a costimulatory receptor Proc Natl Acad Sci U S A 101 2004 3029 3034 (Pubitemid 38327729)
30. + T cell survival J Immunol 172 2004 6065 6073 (Pubitemid 38621208)
31. W. Hsu, S.A. Shu, E. Gershwin, and Z.X. Lian The current immune function of hepatic dendritic cells Cell Mol Immunol 4 2007 321 328
32. + DC correlates with unresponsiveness to imidazoquinolines Eur J Immunol 33 2003 827 833 (Pubitemid 36546669)
33. L. Ma, G. Zhao, C. Hua, X. Li, X. Zhao, and L. Sun Down-regulation of TLR9 expression affects the maturation and function of murine bone marrow-derived dendritic cells induced by CpG Cell Mol Immunol 6 2009 199 205
34. Ma F, Zhang J, Zhang C. The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice. Cell Mol Immunol;7:381-8.
35. S.A. Shu, Z.X. Lian, Y.H. Chuang, G.X. Yang, Y. Moritoki, and S.S. Comstock The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses Clin Exp Immunol 149 2007 335 343 (Pubitemid 47063054)
36. K. Harada, K. Isse, and Y. Nakanuma Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction J Clin Pathol 59 2006 184 190 (Pubitemid 43235585)
37. K. Harada, K. Isse, Y. Sato, S. Ozaki, and Y. Nakanuma Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M Liver Int 26 2006 935 942 (Pubitemid 44323411)
38. Y.H. Paik, R.F. Schwabe, R. Bataller, M.P. Russo, C. Jobin, and D.A. Brenner Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 37 2003 1043 1055 (Pubitemid 36538681)
39. E. Seki, S. De Minicis, C.H. Osterreicher, J. Kluwe, Y. Osawa, and D.A. Brenner TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332 (Pubitemid 350073596)
40. A. Watanabe, A. Hashmi, D.A. Gomes, T. Town, A. Badou, and R.A. Flavell Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9 Hepatology 46 2007 1509 1518 (Pubitemid 350155533)
41. A.P. West, A.A. Koblansky, and S. Ghosh Recognition and signaling by toll-like receptors Annu Rev Cell Dev Biol 22 2006 409 437
42. E.A. Leadbetter, I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors Nature 416 2002 603 607 (Pubitemid 34406754)
43. A. Visintin, A. Mazzoni, J.A. Spitzer, and D.M. Segal Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4 Proc Natl Acad Sci U S A 98 2001 12156 12161 (Pubitemid 32959843)
44. J.C. Chow, D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 274 1999 10689 10692
45. M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, and H. Sanjo Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 301 2003 640 643 (Pubitemid 36927946)
46. M. Carty, R. Goodbody, M. Schroder, J. Stack, P.N. Moynagh, and A.G. Bowie The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling Nat Immunol 7 2006 1074 1081 (Pubitemid 44420652)
47. I. Hritz, A. Velayudham, A. Dolganiuc, K. Kodys, P. Mandrekar, and E. Kurt-Jones Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion Hepatology 48 2008 1342 1347
48. Z. Dong, H. Wei, R. Sun, Z. Hu, B. Gao, and Z. Tian Involvement of natural killer cells in PolyI:C-induced liver injury J Hepatol 41 2004 966 973 (Pubitemid 39575664)
49. X. Hou, R. Zhou, H. Wei, R. Sun, and Z. Tian NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis Hepatology 49 2009 940 949
50. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738 (Pubitemid 33009951)
51. L. Dejager, and C. Libert Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice Cytokine 42 2008 55 61
52. Z. Tu, A. Bozorgzadeh, R.H. Pierce, J. Kurtis, I.N. Crispe, and M.S. Orloff TLR-dependent cross talk between human Kupffer cells and NK cells J Exp Med 205 2008 233 244 (Pubitemid 351185729)
53. Y. Chen, H. Wei, R. Sun, Z. Dong, J. Zhang, and Z. Tian Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells Hepatology 46 2007 706 715 (Pubitemid 47436116)
54. Y. Chen, R. Sun, W. Jiang, H. Wei, and Z. Tian Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner J Hepatol 47 2007 183 190 (Pubitemid 47021249)
55. A. Morikawa, T. Sugiyama, Y. Kato, N. Koide, G.Z. Jiang, and K. Takahashi Apoptotic cell death in the response of d-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model Infect Immun 64 1996 734 738 (Pubitemid 26065541)
56. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci U S A 76 1979 5939 5943 (Pubitemid 10216692)
57. M. Leist, F. Gantner, S. Jilg, and A. Wendel Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release J Immunol 154 1995 1307 1316
58. J.G. Chosay, N.A. Essani, C.J. Dunn, and H. Jaeschke Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury Am J Physiol 272 1997 G1195 G1200
59. M.A. Freudenberg, D. Keppler, and C. Galanos Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin Infect Immun 51 1986 891 895 (Pubitemid 16162992)
60. M. Leist, F. Gantner, I. Bohlinger, G. Tiegs, P.G. Germann, and A. Wendel Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models Am J Pathol 146 1995 1220 1234
61. H. Louis, O. Le Moine, M.O. Peny, B. Gulbis, F. Nisol, and M. Goldman Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury Gastroenterology 112 1997 935 942 (Pubitemid 27113820)
62. A.K. Yi, H. Yoon, J.E. Park, B.S. Kim, H.J. Kim, and A. Martinez-Hernandez CpG DNA-mediated induction of acute liver injury in d-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes J Biol Chem 281 2006 15001 15012 (Pubitemid 43855204)
63. T. Sparwasser, T. Miethke, G. Lipford, A. Erdmann, H. Hacker, and K. Heeg Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock Eur J Immunol 27 1997 1671 1679 (Pubitemid 27302848)
64. A.B. Imaeda, A. Watanabe, M.A. Sohail, S. Mahmood, M. Mohamadnejad, and F.S. Sutterwala Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J Clin Invest 119 2009 305 314
65. S. Wieland, R. Thimme, R.H. Purcell, and F.V. Chisari Genomic analysis of the host response to hepatitis B virus infection Proc Natl Acad Sci U S A 101 2004 6669 6674 (Pubitemid 38586032)
66. H. McClary, R. Koch, F.V. Chisari, and L.G. Guidotti Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines J Virol 74 2000 2255 2264 (Pubitemid 30091480)
67. M. Isogawa, M.D. Robek, Y. Furuichi, and F.V. Chisari Toll-like receptor signaling inhibits hepatitis B virus replication in vivo J Virol 79 2005 7269 7272 (Pubitemid 40677357)
68. T. Ito, R. Amakawa, and S. Fukuhara Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance Hum Immunol 63 2002 1120 1125 (Pubitemid 36025986)
69. A. Cooper, G. Tal, O. Lider, and Y. Shaul Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2 J Immunol 175 2005 3165 3176 (Pubitemid 41170538)
70. J. Wu, Z. Meng, M. Jiang, R. Pei, M. Trippler, and R. Broering Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells Hepatology 49 2009 1132 1140
71. J. Cheng, H. Imanishi, H. Morisaki, W. Liu, H. Nakamura, and T. Morisaki Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1 J Hepatol 43 2005 465 471 (Pubitemid 41111428)
72. Y.M. Loo, D.M. Owen, K. Li, A.K. Erickson, C.L. Johnson, and P.M. Fish Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection Proc Natl Acad Sci U S A 103 2006 6001 6006
73. G. Szabo, and A. Dolganiuc Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection Immunobiology 210 2005 237 247 (Pubitemid 41025165)
74. D.R. Nelson The immunopathogenesis of hepatitis C virus infection Clin Liver Dis 5 2001 931 953 (Pubitemid 33001013)
75. A. Dolganiuc, S. Oak, K. Kodys, D.T. Golenbock, R.W. Finberg, and E. Kurt-Jones Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation Gastroenterology 127 2004 1513 1524 (Pubitemid 39457776)
76. S. Chang, A. Dolganiuc, and G. Szabo Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins J Leukoc Biol 82 2007 479 487 (Pubitemid 47367138)
77. Z. Tu, R.H. Pierce, J. Kurtis, Y. Kuroki, I.N. Crispe, and M.S. Orloff Hepatitis C virus core protein subverts the antiviral activities of human Kupffer cells Gastroenterology 138 2010 305 314
78. K. Machida, K.T. Cheng, V.M. Sung, A.M. Levine, S. Foung, and M.M. Lai Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6 J Virol 80 2006 866 874 (Pubitemid 43062898)
79. M.D. Berzsenyi, S.K. Roberts, S. Preiss, D.J. Woollard, M.R. Beard, and N.A. Skinner Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-alpha in HCV & HCV/HIV infection J Viral Hepat 2010 Epub ahead of print
80. R. Broering, J. Wu, Z. Meng, P. Hilgard, M. Lu, and M. Trippler Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication J Hepatol 48 2008 914 922
81. N. Hosomura, H. Kono, M. Tsuchiya, K. Ishii, M. Ogiku, and M. Matsuda HCV-related proteins activate Kupffer cells isolated from human liver tissues Dig Dis Sci 56 2010 1057 1064
82. A. Dolganiuc, O. Norkina, K. Kodys, D. Catalano, G. Bakis, and C. Marshall Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection Gastroenterology 133 2007 1627 1636 (Pubitemid 350029734)
83. K. Li, E. Foy, J.C. Ferreon, M. Nakamura, A.C. Ferreon, and M. Ikeda Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF Proc Natl Acad Sci U S A 102 2005 2992 2997 (Pubitemid 40299904)
84. M. Otsuka, N. Kato, M. Moriyama, H. Taniguchi, Y. Wang, and N. Dharel Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses Hepatology 41 2005 1004 1012 (Pubitemid 40593908)
85. T. Abe, Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, and S. Taguwa Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88- dependent signaling pathway in macrophage cell lines J Virol 81 2007 8953 8966 (Pubitemid 47311439)
86. N.L. Yonkers, B. Rodriguez, K.A. Milkovich, R. Asaad, M.M. Lederman, and P.S. Heeger TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection J Immunol 178 2007 4436 4444 (Pubitemid 46492395)
87. M. Shiina, and B. Rehermann Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function Hepatology 47 2008 385 395 (Pubitemid 351280706)
88. T. Compton, E.A. Kurt-Jones, K.W. Boehme, J. Belko, E. Latz, and D.T. Golenbock Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2 J Virol 77 2003 4588 4596 (Pubitemid 36402808)
89. K.L. Hokeness-Antonelli, M.J. Crane, A.M. Dragoi, W.M. Chu, and T.P. Salazar-Mather IFN-alphabeta-mediated inflammatory responses and antiviral defense in liver is TLR9-independent but MyD88-dependent during murine cytomegalovirus infection J Immunol 179 2007 6176 6183
90. K. Tabeta, P. Georgel, E. Janssen, X. Du, K. Hoebe, and K. Crozat Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection Proc Natl Acad Sci U S A 101 2004 3516 3521 (Pubitemid 38338227)
91. T. Delale, A. Paquin, C. Asselin-Paturel, M. Dalod, G. Brizard, and E.E. Bates MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo J Immunol 175 2005 6723 6732 (Pubitemid 41598916)
92. E. Szomolanyi-Tsuda, X. Liang, R.M. Welsh, E.A. Kurt-Jones, and R.W. Finberg Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo J Virol 80 2006 4286 4291
93. J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells J Exp Med 198 2003 513 520 (Pubitemid 36976063)
94. J. Zhu, X. Huang, and Y. Yang A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo Mol Ther 16 2008 1300 1307 (Pubitemid 351866062)
95. D.M. Appledorn, S. Patial, A. McBride, S. Godbehere, N. Van Rooijen, and N. Parameswaran Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo J Immunol 181 2008 2134 2144
96. E.A. Carrera-Silva, N. Guinazu, A. Pellegrini, R.C. Cano, A. Arocena, and M.P. Aoki Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection PLoS Negl Trop Dis 4 2010 e863
97. K.J. Hong, J.R. Wickstrum, H.W. Yeh, and M.J. Parmely Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes Infect Immun 75 2007 5338 5345 (Pubitemid 350033621)
98. N. Fausto, J.S. Campbell, and K.J. Riehle Liver regeneration Hepatology 43 2006 S45 S53
99. Y. Yamada, I. Kirillova, J.J. Peschon, and N. Fausto Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor Proc Natl Acad Sci U S A 94 1997 1441 1446 (Pubitemid 27087870)
100. D.E. Cressman, L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, and V. Poli Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice Science 274 1996 1379 1383 (Pubitemid 26391463)
101. W. Li, X. Liang, C. Kellendonk, V. Poli, and R. Taub STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration J Biol Chem 277 2002 28411 28417 (Pubitemid 41079264)
102. Y. Iimuro, T. Nishiura, C. Hellerbrand, K.E. Behrns, R. Schoonhoven, and J.W. Grisham NFkappaB prevents apoptosis and liver dysfunction during liver regeneration J Clin Invest 101 1998 802 811 (Pubitemid 28096077)
103. S. Sakuda, S. Tamura, A. Yamada, J. Miyagawa, K. Yamamoto, and S. Kiso NF-kappaB activation in non-parenchymal liver cells after partial hepatectomy in rats: possible involvement in expression of heparin-binding epidermal growth factor-like growth factor J Hepatol 36 2002 527 533 (Pubitemid 34407342)
104. E. Seki, H. Tsutsui, Y. Iimuro, T. Naka, G. Son, and S. Akira Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration Hepatology 41 2005 443 450 (Pubitemid 40289490)
105. J.S. Campbell, K.J. Riehle, J.T. Brooling, R.L. Bauer, C. Mitchell, and N. Fausto Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4 J Immunol 176 2006 2522 2528 (Pubitemid 43201703)
106. Y. Iimuro, E. Seki, G. Son, H. Tsutsui, K. Nakanishi, and J. Fujimoto Role of innate immune response in liver regeneration J Gastroenterol Hepatol 22 Suppl 1 2007 S57 S58
107. R.P. Cornell, B.L. Liljequist, and K.F. Bartizal Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice Hepatology 11 1990 916 922 (Pubitemid 20221025)
108. G.L. Su, S.C. Wang, A. Aminlari, G.L. Tipoe, L. Steinstraesser, and A. Nanji Impaired hepatocyte regeneration in toll-like receptor 4 mutant mice Dig Dis Sci 49 2004 843 849 (Pubitemid 38870212)
109. K. Akita, M. Okuno, M. Enya, S. Imai, H. Moriwaki, and N. Kawada Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein- mediated activation of latent TGF-beta Gastroenterology 123 2002 352 364 (Pubitemid 34747555)
110. E. Zorde-Khvalevsky, R. Abramovitch, H. Barash, I. Spivak-Pohis, L. Rivkin, and J. Rachmilewitz Toll-like receptor 3 signaling attenuates liver regeneration Hepatology 50 2009 198 206
111. R. Sun, and B. Gao Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma) Gastroenterology 127 2004 1525 1539 (Pubitemid 39457777)
112. R. Sun, O. Park, N. Horiguchi, S. Kulkarni, W.I. Jeong, and H.Y. Sun STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice Hepatology 44 2006 955 966 (Pubitemid 46489560)
113. K. Ojiro, H. Ebinuma, N. Nakamoto, K. Wakabayashi, Y. Mikami, and Y. Ono MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis Biochem Biophys Res Commun 399 2010 744 749
114. X. Xiao, P. Zhao, D. Rodriguez-Pinto, D. Qi, O. Henegariu, and L. Alexopoulou Inflammatory regulation by TLR3 in acute hepatitis J Immunol 183 2009 3712 3719
115. J. Wang, R. Sun, H. Wei, Z. Dong, B. Gao, and Z. Tian Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism J Hepatol 44 2006 446 454 (Pubitemid 43227868)
116. W. Jiang, R. Sun, H. Wei, and Z. Tian Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages Proc Natl Acad Sci U S A 102 2005 17077 17082 (Pubitemid 41692686)
117. T.R. Gardner, Q. Chen, Y. Jin, and M.N. Ajuebor Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells Am J Pathol 176 2010 1779 1789
118. + NKT cells J Immunol 182 2009 3768 3774
119. H. Zhang, Q. Gong, J.H. Li, X.L. Kong, L. Tian, and L.H. Duan CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice Int Immunopharmacol 10 2010 79 85
120. G.B. Lipford, T. Sparwasser, M. Bauer, S. Zimmermann, E.S. Koch, and K. Heeg Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines Eur J Immunol 27 1997 3420 3426 (Pubitemid 28018040)
121. A.H. Dalpke, M.D. Lehner, T. Hartung, and K. Heeg Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance Immunology 116 2005 203 212 (Pubitemid 41368662)
122. Y.I. Kim, J.E. Park, A. Martinez-Hernandez, and A.K. Yi CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases J Biol Chem 283 2008 15258 15270
123. L. Romics Jr., A. Dolganiuc, A. Velayudham, K. Kodys, P. Mandrekar, and D. Golenbock Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni-bacterium acnes J Leukoc Biol 78 2005 1255 1264 (Pubitemid 41779231)
124. C. Kalis, M. Gumenscheimer, N. Freudenberg, S. Tchaptchet, G. Fejer, and A. Heit Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes J Immunol 174 2005 4295 4300 (Pubitemid 40396011)
125. A. Velayudham, I. Hritz, A. Dolganiuc, P. Mandrekar, E. Kurt-Jones, and G. Szabo Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury J Hepatol 45 2006 813 824 (Pubitemid 44646677)
126. L. Romics Jr., A. Dolganiuc, K. Kodys, Y. Drechsler, S. Oak, and A. Velayudham Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice Hepatology 40 2004 555 564 (Pubitemid 39265576)
127. R.D. Weeratna, S.R. Makinen, M.J. McCluskie, and H.L. Davis TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848) Vaccine 23 2005 5263 5270 (Pubitemid 41443432)
128. R. Ma, J.L. Du, J. Huang, and C.Y. Wu Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination Biochem Biophys Res Commun 361 2007 537 542 (Pubitemid 47187279)
129. A.J. Thompson, D. Colledge, S. Rodgers, R. Wilson, P. Revill, and P. Desmond Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro Antivir Ther 14 2009 797 808
130. Y. Horsmans, T. Berg, J.P. Desager, T. Mueller, E. Schott, and S.P. Fletcher Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection Hepatology 42 2005 724 731 (Pubitemid 41233667)
131. J. Lee, C.C. Wu, K.J. Lee, T.H. Chuang, K. Katakura, and Y.T. Liu Activation of anti-hepatitis C virus responses via Toll-like receptor 7 Proc Natl Acad Sci U S A 103 2006 1828 1833 (Pubitemid 43228778)
132. A.X. Xiang, S.E. Webber, B.M. Kerr, E.J. Rueden, J.R. Lennox, and G.J. Haley Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribine Nucleosides Nucleotides Nucleic Acids 26 2007 635 640 (Pubitemid 350239237)
133. H. Kanzler, F.J. Barrat, E.M. Hessel, and R.L. Coffman Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists Nat Med 13 2007 552 559 (Pubitemid 46830615)
134. A. Tsung, S.L. McCoy, J.R. Klune, D.A. Geller, T.R. Billiar, and S.H. Hefeneider A novel inhibitory peptide of Toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice Shock 27 2007 364 369 (Pubitemid 46594966)